Emily F. Gaudiano

Brigham and Women's Hospital — United States

Medicine · Health Sciences

7h-index1.0kcitations57works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(28), Immune Cell Function and Interaction(24), Diabetes and associated disorders(12), Tryptophan and brain disorders(10), Immune cells in cancer(9)

Publications57 total

Supplementary Figure 6 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 15 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 5 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 12 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 7 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 13 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 14 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 15 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 4 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 13 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 14 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 3 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 2 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 2 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Data from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 8 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 3 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 9 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 6 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
Supplementary Figure 10 from Formate Supplementation Enhances Antitumor CD8<sup>+</sup> T-cell Fitness and Efficacy of PD-1 Blockade
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Arlene H. Sharpe(43), Martin W. LaFleur(42), Marcia C. Haigis(41), Gordon J. Freeman(33), Jared H. Rowe(32), Ilaria Elia(32), Osmaan Shahid(32), Natalia E. Sifnugel(32), Sheila Johnson(32), Amy G. Reynolds(32), Megan E. Fung(32), Shakchhi Joshi(32), Joon Seok Park(32), Kristen E. Pauken(32), Joshua D. Rabinowitz(32), Jacob E. Gillis(10), Jefte M. Drijvers(9), Tara Muijlwijk(9), Isaac S. Harris(9), Alison E. Ringel(9)